LLY has been in the news 319% more than usual
Jan 08, 2026, 1:31 PM
-7.82%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Lilly (Eli) & Company operates within a competitive biopharmaceutical landscape, where companies like Pfizer are facing significant revenue losses due to patent expirations, prompting increased merger and acquisition activity. Additionally, the performance of health care ETFs is expected to improve in 2026 as investors become cautious about high valuations in the AI sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.